+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Intragastric Balloon Market By Administration, By Type, By Filling Material, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5026328
  • Report
  • April 2020
  • Region: Europe
  • 81 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Apollo Endosurgery, Inc.
  • Districlass Medical SA
  • Medsil
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Spatz FGIA, Inc.
The Europe Intragastric Balloon Market is expected to witness market growth of 12% CAGR during the forecast period (2020-2026).

The cost-effectiveness and safety of intragastric balloons is expected to play an important role in market growth. The treatments for intragastric balloon implantation are safer and lower-cost alternatives to bariatric surgery, which is an invasive weight loss procedure that causes multiple risks after surgery. The cost of these procedures is also considerably higher than the intragastric balloons plantation. Therefore, non-surgical and less-invasive weight loss procedures such as intragastric balloon implantation are becoming increasingly common.

Vendors' growing concentration on technical developments, which is one of the key intragastric balloon industry trends, will also drive market growth. Different leading vendors concentrate on improving the capabilities and performance of intragastric balloon devices. The manufacturers also focus on balloon volume changes and longer implantation time. Minimally-invasive procedures are required for the implantation of the intragastric balloon, which can be conveniently carried out in an ambulatory environment. A single endoscopic procedure can be used to position an intragastric balloon, and it is easily reversible.

In 2018, France's intragastric balloons market recorded a substantial market share due to increased demand for weight-loss procedures. According to the OECD, one in ten people is obese and in France, 40 percent is overweight. Strong demand for weight-loss strategies as a result of rising obesity prevalence is expected to stimulate potential business growth.

Based on Administration, the market is segmented into Endoscopy and Pill Form. Based on Type, the market is segmented into Single, Dual and Triple. Based on Filling Material, the market is segmented into Gas Filled and saline Filled. Based on End Use, the market is segmented into Clinics, Hospitals and Ambulatory Surgical Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil

Scope of the Study

Market Segmentation:

By Administration
  • Endoscopy and
  • Pill Form

By Type
  • Single
  • Dual and
  • Triple

By Filling Material
  • Gas Filled and
  • Saline Filled

By End Use
  • Clinics
  • Hospitals and
  • Ambulatory Surgical Centers

By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled:
  • Sientra, Inc. (Silimed, Inc.)
  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Allurion Technologies, Inc.
  • Helioscopie SA (Sante Actions Group)
  • Districlass Medical SA
  • Spatz FGIA, Inc.
  • Duomed Group (Life Partners Europe)
  • Medsil

Unique Offerings from the Publisher:
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Apollo Endosurgery, Inc.
  • Districlass Medical SA
  • Medsil
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Spatz FGIA, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Intragastric Balloon Market, by Administration
1.4.2 Europe Intragastric Balloon Market, by Type
1.4.3 Europe Intragastric Balloon Market, by Filling Material
1.4.4 Europe Intragastric Balloon Market, by End Use
1.4.5 Europe Intragastric Balloon Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Intragastric Balloon Market by Administration
3.1 Europe Endoscopy Market by Country
3.2 Europe Pill Form Market by Country
Chapter 4. Europe Intragastric Balloon Market by Type
4.1 Europe Single Market by Country
4.2 Europe Dual Market by Country
4.3 Europe Triple Market by Country
Chapter 5. Europe Intragastric Balloon Market by Filling Material
5.1 Europe Gas Filled Intragastric Balloon Market by Country
5.2 Europe Saline Filled Intragastric Balloon Market by Country
Chapter 6. Europe Intragastric Balloon Market by End-use
6.1 Europe Clinics Intragastric Balloon Market by Country
6.2 Europe Hospitals Market by Country
6.3 Europe Ambulatory Surgical Centers Market by Country
Chapter 7. Europe Intragastric Balloon Market by Country
7.1 Germany Intragastric Balloon Market
7.1.1 Germany Intragastric Balloon Market by Administration
7.1.2 Germany Intragastric Balloon Market by Type
7.1.3 Germany Intragastric Balloon Market by Filling Material
7.1.4 Germany Intragastric Balloon Market by End-use
7.2 UK Intragastric Balloon Market
7.2.1 UK Intragastric Balloon Market by Administration
7.2.2 UK Intragastric Balloon Market by Type
7.2.3 UK Intragastric Balloon Market by Filling Material
7.2.4 UK Intragastric Balloon Market by End-use
7.3 France Intragastric Balloon Market
7.3.1 France Intragastric Balloon Market by Administration
7.3.2 France Intragastric Balloon Market by Type
7.3.3 France Intragastric Balloon Market by Filling Material
7.3.4 France Intragastric Balloon Market by End-use
7.4 Russia Intragastric Balloon Market
7.4.1 Russia Intragastric Balloon Market by Administration
7.4.2 Russia Intragastric Balloon Market by Type
7.4.3 Russia Intragastric Balloon Market by Filling Material
7.4.4 Russia Intragastric Balloon Market by End-use
7.5 Spain Intragastric Balloon Market
7.5.1 Spain Intragastric Balloon Market by Administration
7.5.2 Spain Intragastric Balloon Market by Type
7.5.3 Spain Intragastric Balloon Market by Filling Material
7.5.4 Spain Intragastric Balloon Market by End-use
7.6 Italy Intragastric Balloon Market
7.6.1 Italy Intragastric Balloon Market by Administration
7.6.2 Italy Intragastric Balloon Market by Type
7.6.3 Italy Intragastric Balloon Market by Filling Material
7.6.4 Italy Intragastric Balloon Market by End-use
7.7 Rest of Europe Intragastric Balloon Market
7.7.1 Rest of Europe Intragastric Balloon Market by Administration
7.7.2 Rest of Europe Intragastric Balloon Market by Type
7.7.3 Rest of Europe Intragastric Balloon Market by Filling Material
7.7.4 Rest of Europe Intragastric Balloon Market by End-use
Chapter 8. Company Profiles
8.1 Sientra, Inc. (Silimed, Inc.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Apollo Endosurgery, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals:
8.3 Obalon Therapeutics, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.3.5.2 Partnerships, Collaborations, and Agreements:
8.3.5.3 Geographical Expansions:
8.4 ReShape Lifesciences, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research and Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Allurion Technologies, Inc.
8.5.1 Company Overview
8.6 Helioscopie SA (Sante Actions Group)
8.6.1 Company Overview
8.7 Districlass Medical SA
8.7.1 Company Overview
8.8 Spatz FGIA, Inc.
8.8.1 Company Overview
8.9 Duomed Group (Life Partners Europe)
8.9.1 Company Overview
8.1 Medsil
8.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Sientra, Inc. (Silimed, Inc.)
  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Allurion Technologies, Inc.
  • Helioscopie SA (Sante Actions Group)
  • Districlass Medical SA
  • Spatz FGIA, Inc.
  • Duomed Group (Life Partners Europe)
  • Medsil
Note: Product cover images may vary from those shown

Loading
LOADING...